New York, New York – Every Cure, a nonprofit organization dedicated to unlocking the full potential of existing drugs for the treatment of various diseases, was highlighted at Clinton Foundation Gala. Co-founder Dr. David Fajgenbaum addressed attendees on the incredible progress Every Cure has made to date. The event, held in New York, celebrated the organization’s achievements and highlighted the urgent need for drug repurposing in healthcare.
In March 2021, Dr. David Fajgenbaum received a life-changing phone call. On the other end of the line was the 42nd President of the United States, Bill Clinton. President Clinton had read Fajgenbaum’s book and was astonished that a drug with the potential to save lives had gone unrecognized for years. He asked Fajgenbaum how many more drugs could be repurposed to save countless lives. Fajgenbaum expressed the immense number of untapped possibilities due to a broken system that lacks incentives for exploring new uses of existing drugs, particularly generic ones.
Inspired by President Clinton’s support and the success of the Clinton Health Access Initiative, Fajgenbaum launched Every Cure—an initiative aimed at unlocking the full potential of every FDA-approved drug for the treatment of all possible diseases. The organization utilizes artificial intelligence to identify the most promising drug candidates for various diseases and accelerate their entry into clinical trials.
Since the announcement, Every Cure has made remarkable progress. For the first time, they have predicted the potential for every single drug to treat every single disease. Notably, they have already achieved life-saving results, including a patient named Albert, whose life was saved by a repurposed drug recommended by Every Cure.
In his speech, Fajgenbaum emphasized the pressing need to address diseases without approved therapies, especially considering that 1 in 10 children will develop such diseases. Repurposing drugs offers a cost-effective solution, with the potential to save lives at a fraction of the cost required for new drug development.
Fajgenbaum expressed profound gratitude to the Clinton family and the foundation for their unwavering support. He invited attendees of the Clinton Global Initiative to join Every Cure’s mission by donating funds, contributing data, and forming partnerships. By harnessing the power of drug repurposing and collective efforts, the goal of revolutionizing medicine and providing hope to countless patients can be realized.